[1] Dougherty T J, Gomer C J, Henderson B W et al. Photodynamic therapy[J]. Journal of the National Cancer Institute, 90, 889-905(1998).

[2] Allison R R, Mota H C, Bagnato V S et al. Bio-nanotechnology and photodynamic therapy-state of the art review[J]. Photodiagnosis and Photodynamic Therapy, 5, 19-28(2008). http://www.europepmc.org/abstract/MED/19356632

[3] Lyons M, Phang I, Eljamel S. The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy[J]. Photodiagnosis and Photodynamic Therapy, 9, 40-45(2012). http://www.ncbi.nlm.nih.gov/pubmed/22369727

[4] Paszko E, Ehrhardt C, Senge M O et al. Nanodrug applications in photodynamic therapy[J]. Photodiagnosis and Photodynamic Therapy, 8, 14-29(2011). http://www.ncbi.nlm.nih.gov/pubmed/21333931

[5] Gary-Bobo M, Hocine O, Brevet D et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT[J]. International Journal of Pharmaceutics, 423, 509-515(2012). http://www.sciencedirect.com/science/article/pii/S0378517311010866

[6] Senge M O. mTHPC-A drug on its way from second to third generation photosensitizer?[J]. Photodiagnosis and Photodynamic Therapy, 9, 170-179(2012). http://www.ncbi.nlm.nih.gov/pubmed/22594988

[7] Shibu E S, Hamada M, Murase N et al. Nanomaterials formulations for photothermal and photodynamic therapy of cancer[J]. Journal of Photochemistry and Photobiology C: Photochemistry Reviews, 15, 53-72(2013). http://www.sciencedirect.com/science/article/pii/S1389556712000664

[8] Huang K Q, Chen L, Xiong J W et al. Preparation and characterization of visible-light-activated Fe-N Co-doped TiO2 and its photocatalytic inactivation effect on leukemia tumors[J]. International Journal of Photoenergy, 2012, 1910-1912(2012). http://www.oalib.com/paper/43926

[9] Akpan U G, Hameed B H. Parameters affecting the photocatalytic degradation of dyes using TiO2-based photocatalysts: a review[J]. Journal of Hazardous Materials, 170, 520-529(2009). http://www.ncbi.nlm.nih.gov/pubmed/19505759

[10] Medintz I L, Mattoussi H. Quantum dot-based resonance energy transfer and its growing application in biology[J]. Physical Chemistry Chemical Physics, 11, 17-45(2009). http://europepmc.org/abstract/med/19081907

[11] Yaghini E, Seifalian A M, Macrobert A J. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy[J]. Nanomedicine, 4, 353-363(2009). http://www.ncbi.nlm.nih.gov/pubmed/19331542?dopt=AbstractPlus

[12] Garcia A M F, Fernandes M S F, Coutinho P J G. CdSe/TiO2 core-shell nanoparticles produced in AOT reverse micelles: applications in pollutant photodegradation using visible light[J]. Nanoscale Research Letters, 6, 1-4(2011). http://europepmc.org/articles/PMC3211843

[13] Feng H, Thanhthuy T T, Chen Let al. Visible light-induced efficiently oxidative decomposition of p-Nitrophenol by CdTe/TiO2 nanotube arrays[J]. 215-, 216, 591-599(2013).

[14] Zhang J Z, Gao S M, Song J et al. Research development on CdSe/TiO2 nanocomposites[J]. Micronanoelectronic Technology, 48, 26-36(2011).

[15] Xue T, Guo W B, Liang X Y et al. An experimental study on the visible light inactivated HL60 cells in vitro based on CdSe doped anatase TiO2[J]. Acta Laser Biology Sinica, 26, 224-231(2017).

[16] Parker N, Turk M J, Westrick E et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay[J]. Analytical Biochemistry, 338, 284-293(2005). http://europepmc.org/abstract/MED/15745749

[17] Hilgenbrink A R, Low P S. Folate receptor-mediated drug targeting from therapeutics to diagnostics[J]. Journal of Pharmaceutical Sciences, 94, 2135-2146(2005). http://old.med.wanfangdata.com.cn/viewHTMLEn/PeriodicalPaper_JJ026725853.aspx

[18] Ross J F, Wang H, Behm F G et al. Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia[J]. Cancer, 85, 348-357(1999). http://europepmc.org/abstract/MED/10023702

[19] Pan X Q, Zheng X, Shi G et al. Strategy for the treatment of acute myelogenous leukemia based on folate receptor β-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid[J]. Blood, 100, 594-602(2002). http://www.bloodjournal.org/content/100/2/594?sso-checked=1

[20] Fu Q W, Xue X Y, Xue T et al. An experimental study on the photocatalytic inactivation of HL60 cells in vitro based on sulfur-doped titanium dioxide modified folic acid[J]. Acta Laser Biology Sinica, 26, 30-36(2017).

[21] Li L L, Zheng Z L, Huang K Q et al. ROS detection in HL60 based on ALA-PDT[J]. Optoelectronics, 1, 11-15(2011).

[22] Xiong J W, Xiao H, Zhang Z X. An experimental research on different detections between MTT and CCK-8[J]. Acta Laser Biology Sinica, 16, 559-562(2007).

[23] Monshi A, Foroughi M R, Monshi M R. Modified Scherrer equation to estimate more accurately nano-crystallite size using XRD[J]. World Journal of Nano Science and Engineering, 2, 154-160(2012). http://www.oalib.com/paper/14698

[24] Harada Y, Ogawa K, Irie Y et al. Ultrasound activation of TiO2 in melanoma tumors[J]. Journal of Controlled Release, 149, 190-195(2011). http://agris.fao.org/agris-search/search.do?recordID=US201500181606

[25] Irena M, Jarmila K. Role of ER stress response in photodynamic therapy: ROS generated in different subcellular compartments trigger diverse cell death pathways[J]. Plos One, 7, e32972(2012). http://pubmedcentralcanada.ca/pmcc/articles/PMC3293927/

[26] Chen Y K, Senadi G C, Lee C H et al. Apoptosis induced by 2-aryl benzothiazoles-mediated photodynamic therapy in melanomas via mitochondrial dysfunction[J]. Chemical Research in Toxicology, 27, 1187-1198(2014). http://pubs.acs.org/doi/abs/10.1021/tx500080w